Shandong Buchang Pharmaceuticals Co Ltd (603858) — Cash Flow Quality Index
Shandong Buchang Pharmaceuticals Co Ltd (603858) has a Cash Flow Quality Index of -0.60x as of September 2025. Operating cash flow of CN¥-145.26 Million is below net income of CN¥240.62 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Shandong Buchang Pharmaceuticals Co Ltd asset portfolio for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shandong Buchang Pharmaceuticals Co Ltd Cash Flow Quality Index (2012–2023)
Historical Cash Flow Quality Index for Shandong Buchang Pharmaceuticals Co Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shandong Buchang Pharmaceuticals Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shandong Buchang Pharmaceuticals Co Ltd (2012–2023)
Year-by-year earnings quality comparison for Shandong Buchang Pharmaceuticals Co Ltd. For live market cap and the full company financial profile, see market value of Shandong Buchang Pharmaceuticals Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -1.08x | CN¥-164.26 Million | CN¥151.87 Million | ▼ -201.2% |
| 2021 | 1.07x | CN¥1.32 Billion | CN¥1.24 Billion | ▲ +0.6% |
| 2020 | 1.06x | CN¥1.96 Billion | CN¥1.84 Billion | ▼ -20.4% |
| 2019 | 1.34x | CN¥2.62 Billion | CN¥1.96 Billion | ▲ +24.2% |
| 2018 | 1.08x | CN¥2.05 Billion | CN¥1.91 Billion | ▼ -10.2% |
| 2017 | 1.20x | CN¥1.96 Billion | CN¥1.64 Billion | ▲ +27.0% |
| 2016 | 0.94x | CN¥1.67 Billion | CN¥1.77 Billion | ▲ +57.1% |
| 2015 | 0.60x | CN¥2.12 Billion | CN¥3.53 Billion | ▼ -49.1% |
| 2014 | 1.18x | CN¥1.78 Billion | CN¥1.51 Billion | ▲ +42.8% |
| 2013 | 0.83x | CN¥1.11 Billion | CN¥1.35 Billion | ▼ -23.3% |
| 2012 | 1.08x | CN¥1.35 Billion | CN¥1.25 Billion | — |